NCT01263197 A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol Status COMPLETED Phase PHASE1
NCT01263093 A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel Status COMPLETED Phase PHASE1
NCT01260649 N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression Status TERMINATED Phase PHASE4
NCT01254305 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01250873 A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline Status COMPLETED Phase PHASE1
NCT01244854 Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness Status COMPLETED Phase NA
NCT01243957 A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. Status COMPLETED Phase PHASE1
NCT01239888 Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study Status UNKNOWN Phase PHASE1
NCT01234558 Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression Status COMPLETED Phase PHASE2
NCT01226238 Online Self-help for Depressed Patients Awaiting Psychotherapy Status TERMINATED Phase NA
NCT01221935 Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder Status COMPLETED Phase N/A
NCT01217645 Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration Status COMPLETED Phase PHASE1
NCT01207271 A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings Status COMPLETED Phase NA
NCT01203683 Testing the Effectiveness of a Computer-based Program for Depression Status COMPLETED Phase PHASE3
NCT01198795 Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01198561 Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression Status UNKNOWN Phase N/A